Dongguk University Researchers Describe Recent Advances in Carcinomas (Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines)

Media coverage

• Title	Dongguk University Researchers Describe Recent Advances in Carcinomas (Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines)
  Media name/outlet	Clinical Oncology Daily
  Country/Territory	United States
  Date	13/12/23
  Persons	Won Jun Choi, Kyeong Lee